Elissa M Ozanne1, Elisabeth R Silver2, Sameer D Saini3,4,5, Joel H Rubenstein3,6, Iris Lansdorp-Vogelaar7, Nicole Bowers4, Sarah Xinhui Tan2, John M Inadomi8, Chin Hur2,9,10. 1. Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, Utah, USA. 2. Division of General Medicine, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA. 3. VA Ann Arbor Health Services Research and Development Center of Clinical Management Research, Ann Arbor, Michigan, USA. 4. Division of Gastroenterology and Hepatology, Department of Internal Medicine, Michigan Medicine, Ann Arbor, Michigan, USA. 5. Michigan Integrated Center for Health Analytics and Medical Prediction (MiCHAMP), Ann Arbor, Michigan, USA. 6. Barrett's Esophagus Program, Division of Gastroenterology, University of Michigan, Ann Arbor, Michigan, USA. 7. Department of Public Health, Erasmus MC, University Medical Center Rotterdam, the Netherlands. 8. Department of Medicine, University of Utah School of Medicine, Salt Lake City, Utah, USA. 9. Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA. 10. Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USA.
Abstract
INTRODUCTION: Regular endoscopic surveillance is the gold standard Barrett's esophagus (BE) surveillance, yet harms of surveillance for some patients may outweigh the benefits. We sought to characterize physicians' BE surveillance cessation recommendations. METHODS: We surveyed gastroenterologists about their BE surveillance recommendations varying patient age, comorbidity, and BE length. RESULTS: Clinicians varied in recommendations for repeat surveillance. Patient age showed the largest variation among decisions, whereas BE length varied the least. DISCUSSION: Age and comorbidities seem to influence BE surveillance cessation decisions, but with variation. Clear cessation guidelines balancing the risks and benefits for BE surveillance are warranted.
INTRODUCTION: Regular endoscopic surveillance is the gold standard Barrett's esophagus (BE) surveillance, yet harms of surveillance for some patients may outweigh the benefits. We sought to characterize physicians' BE surveillance cessation recommendations. METHODS: We surveyed gastroenterologists about their BE surveillance recommendations varying patient age, comorbidity, and BE length. RESULTS: Clinicians varied in recommendations for repeat surveillance. Patient age showed the largest variation among decisions, whereas BE length varied the least. DISCUSSION: Age and comorbidities seem to influence BE surveillance cessation decisions, but with variation. Clear cessation guidelines balancing the risks and benefits for BE surveillance are warranted.
Authors: Anna Tavakkoli; Henry D Appelman; David G Beer; Chaitra Madiyal; Maryam Khodadost; Kimberly Nofz; Val Metko; Grace Elta; Thomas Wang; Joel H Rubenstein Journal: Clin Gastroenterol Hepatol Date: 2018-02-09 Impact factor: 11.382
Authors: Joel H Rubenstein; Heiko Pohl; Megan A Adams; Eve Kerr; Robert Holleman; Sandeep Vijan; Jason A Dominitz; John M Inadomi; Dawn Provenzale; Joseph Francis; Sameer D Saini Journal: Am J Gastroenterol Date: 2017-07-11 Impact factor: 10.864
Authors: Joel H Rubenstein; Mohamed Noureldin; Anna Tavakkoli; Chin Hur; Amir-Houshang Omidvari; Akbar K Waljee Journal: Gastroenterology Date: 2019-10-31 Impact factor: 22.682